Icon

ORSERDU - (345MG, 86MG)

ELACESTRANT HYDROCHLORIDE None
345MG, 86MG
Less Than $1000 mn
None None
None None
None None
ORSERDU is an estrogen receptor antagonist indicated for: • treatment of postmenopausal women or adult men, with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.
Yes
ORSERDU Patent 1 Patent 2 Patent 3 Patent 4 Patent 5 Patent 6 Patent 7 Patent 8
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.